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Abstract
The expression, localization, and regulation of aquaporin 5 (AQP5), a member of the water channel family of proteins, was
investigated in tissues of the rat gastrointestinal tract. Reverse transcriptase^polymerase chain reaction (RT^PCR) detected
AQP5 mRNA in the lower stomach and duodenum. DNA sequencing confirmed that the cDNA fragment amplified had the
complete sequence of the AQP5 cDNA fragment. Western blot analysis indicated the expression of a 27 kDa molecular mass
AQP5 protein in the lower stomach and duodenum, which size was the same as that found for the protein in the
submandibular gland and lungs. By immunohistochemistry using the IgG affinity-purified AQP5 antibody, the pyloric gland
and Brunner’s gland were primarily stained in the lower stomach and duodenum, respectively; a strong staining appeared in
the apical and lateral membranes in both glands. These results indicate that AQP5 is present in the rat lower stomach and
duodenum where it may be involved in a water transport mechanism. These results also support the idea that AQP5, and
probably other aquaporins, are involved in water secretion in the stomach and duodenum although the volume of water
transported via AQPs is unclear. ß 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Aquaporins (AQPs) are a family of water channel
proteins existing in mammals, plants, and microor-
ganisms. Mammalian AQPs selectively transport
water or water and solutes such as glycerol and
urea [1^6]. Currently, there are 11 mammalian
AQPs expressed in various tissues [7^11]. Among
them, AQP1 was the ¢rst AQP identi¢ed. It was
isolated from human erythrocytes and is expressed
in various endothelial and epithelial tissues [12^15];
AQP2 is expressed in the kidney collecting duct cells,
and its cellular localization is regulated by vasopres-
sin [2,16]. AQP3 and AQP4 are localized in the kid-
ney collecting duct cells and epithelial cells of the
digestive tract [17,18]; the latter is a mercury-insen-
sitive water channel and is also expressed in the brain
[4,19]. AQP6, AQP7, AQP8, and AQP9 are known
to be expressed in either one or more of the follow-
0167-4889 / 02 / $ ^ see front matter ß 2002 Elsevier Science B.V. All rights reserved.
PII: S 0 1 6 7 - 4 8 8 9 ( 0 1 ) 0 0 1 7 2 - 0
Abbreviations: AQP5, aquaporin 5; EDTA, ethylenediamine-
tetraacetic acid; PBS, phosphate-bu¡ered saline; PKA, protein
kinase A; PMSF, phenylmethylsulfonyl £uoride; RT^PCR, re-
verse transcriptase^polymerase chain reaction; SDS^PAGE, so-
dium dodecyl sulfate^polyacrylamide gel electrophoresis; TAE,
Tris-acetate bu¡er containing ethylenediaminetetraacetic acid
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ing: renal epithelium, testis, pancreas, liver, and pe-
ripheral leukocytes. AQP5 is a water channel, the
cDNA of which was ¢rst isolated by Raina et al.
[6]. This water channel is strongly expressed in the
salivary gland, lacrimal gland, lungs, eyes, and tra-
chea [6], many of which secrete water in an exocrine
fashion. Water movement across the cell membrane
is signi¢cantly elevated in MDCK cells transfected
with the AQP5 gene [20], whereas salivary secretion
is dramatically diminished in AQP5-knock out mice
[21]. These studies directly demonstrate that AQP5
plays a pivotal role in the production of saliva and
probably in that of other £uid secretions of the exo-
crine type. In the gastrointestinal tract, in situ hy-
bridization techniques have demonstrated the cellular
localization of AQP1, AQP3, AQP4, and AQP8; but
no AQP2 or AQP5 mRNA was detected [22]. The
gastrointestinal tissues also transport a large amount
of water in an exocrine fashion. Yet the presence of
AQP5 or some as yet unrecognized AQP responsible
for such water transport has not been detected. The
present study analyzed on rat gastrointestinal tissues
for AQP5 expression.
2. Materials and methods
2.1. Reagents
Tri-reagent and propidium iodide were purchased
from Sigma Chemical Co. (St. Louis, MO), whereas
SuperScript One Step RT^PCR system was from
Life Technologies Gibco BRL (Gaithersburg, MD).
ECL detection kit, and protein A Sepharose were
from Amersham Pharmacia Biotech (Buckingham-
shire, UK). Complete EDTA-free protease inhibitor
cocktail tablets were from Boehringer Mannheim
(Mannheim, Germany). Fuji RX X-ray ¢lm was pro-
cured from Fuji Film Co. (Kanagawa, Japan),
whereas £uorescein (FITC)-conjugated A⁄niPure
goat anti-rabbit IgG (H+L) was from Jackson Im-
muno Research (West Grove, PA). Tissue-Tek Oct
compound was obtained from Sakura Finetechnical
(Tokyo, Japan), and APS-coated micro slide glasses
and micro cover glasses were from Matsunami Glass
(Osaka, Japan). DNA ladder size marker (100 bp)
was from New England Biolabs (Beverly, MA).
Phenylmethylsulfonyl £uoride (PMSF) and aprotinin
were purchased from Wako Pure Chemicals (Osaka,
Japan), while pepstatin A and leupeptin were from
Peptide Institute (Osaka, Japan). Bio-Rad protein
assay kit was obtained from Bio-Rad Laboratories
(Hercules, CA). Anti-rat AQP5 antiserum was pre-
pared in our laboratory [23]. The antibody was then
IgG a⁄nity-puri¢ed by using a protein A Sepharose
column.
2.2. Animals and tissue excision
Male Sprague^Dawley rats weighing 260^280 g
were killed by cervical dislocation, and various tis-
sues were excised: submandibular gland, extraorbital
lacrimal gland, lung, upper stomach, lower stomach,
duodenum, jejunum, ileum, caecum, colon, and rec-
tum. Special care was taken when the gastrointestinal
tissues were dissected; borders between the rectum
and colon and between the duodenum and jejunum
were carefully identi¢ed. These tissues were dissected
such that they would contain no contaminating tis-
sue. The tissue immediately before the caecum was
identi¢ed as the ileum, and was carefully dissected
away from extraneous tissues. The intestinal tissue
approximately located in the initial one-fourth of
the total small intestine was considered to be the
middle of the jejunum, and the tissue below this
point was taken as the jejunum sample. The tissue
immediately after the transverse colon (descending
colon) was identi¢ed and taken as the colon sample.
An approximate 2-cm length of each of these tissues
was used for RNA and protein preparation as de-
scribed below.
2.3. RNA preparation, RT^PCR, and DNA
sequencing
Tissues for RNA preparation were quickly pro-
cessed and total RNA was isolated by using Tri-re-
agent according to the manufacturer’s protocol. RT^
PCR ampli¢cation was performed by using a Super-
Script One Step RT^PCR system. To a ¢nal volume
of 25 Wl, the following components were mixed on ice
(2‡C): 12.5 Wl of 2U reaction mixture (0.4 mM con-
centration of each dNTP and 2.4 mM MgSO4),
5 pmol of each primer, 0.5 Wl of RT/Taq mix, and
0.5 Wg of template RNA. The RT reaction (cDNA
synthesis) was carried out at 45‡C for 30 min. The
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reaction mixture was then incubated at 94‡C for
2 min to inactivate the enzyme and to denature the
RNA/cDNA hybrid. The DNA ampli¢cation by
PCR was next performed for 35 cycles (Takara Ther-
mal Cycler MP, model TP3000), each cycle consist-
ing of denaturation at 94‡C for 15 s, primer anneal-
ing at 55‡C for 30 s, and extension at 72‡C for 1.5
min. Some of the primer sets used in the present
study were designed according to the published se-
quences, whereas others were those that had been
reported earlier [24,25]. Primer sequences are sum-
marized in Table 1. A 2-Wl volume of the RT^PCR
product was size fractionated in 1.5% agarose in
TAE, and stained with ethidium bromide (2 Wg/ml)
for analysis by a standard procedure. In some experi-
ments, the RT^PCR products were puri¢ed by aga-
rose gel electrophoresis and ethanol precipitated, and
subjected to DNA sequencing with a Genetic Ana-
lyzer (Perkin-Elmer, USA).
2.4. Preparation of the total and apical membrane
fractions and Western blotting
Tissue specimens were dissected as described above
and homogenized in 9 volumes (w/v) of ice-cold ho-
mogenization bu¡er (5 mM HEPES bu¡er (pH 7.5),
50 mM mannitol, 0.25 M MgCl2, 1 mM PMSF, 1 Wg/
ml aprotinin, 2 Wg/ml pepstatin A, 2 Wg/ml leupeptin,
and 1 tablet of Complete EDTA-free protease inhib-
itor cocktail per 25 ml of bu¡er) by using a 15-ml
taper-type glass mortar ¢tted with a Te£on pestle
(Wheaton Science Products, Milliville, NJ). The ho-
mogenate was ¢ltered through a nylon mesh (150
mesh), and the nuclear fraction was removed by cen-
trifugation at 800Ug for 5 min at 2‡C. The super-
natant thus obtained was centrifuged at 105 000Ug
for 1 h at 2‡C to obtain the total membrane fraction,
which was next suspended in homogenization bu¡er.
For preparation of the apical membrane fraction,
the homogenate was prepared with the same bu¡er
as that described above except the MgCl2 concentra-
tion was decreased to 0.25 mM. The homogenate
was ¢ltered through a nylon mesh and centrifuged
at 800Ug. The supernatant was next subjected to
di¡erential centrifugation and MgCl2 treatment ac-
cording to the procedure described earlier [26,27];
the purity of the apical membrane thus obtained
was con¢rmed previously by measuring marker en-
zymes [27].
Protein concentrations were determined by a Bio-
Rad protein assay kit, with bovine serum albumin
used as a standard [28]. Protein samples (10 Wg
each) and standard molecular mass protein markers
were electrophoretically resolved in 12% polyacryl-
amide slab gels. After electrophoresis, the proteins
separated on the gel were transferred onto a nitro-
cellulose ¢lter by means of a Bio-Rad Mini Trans
Blot apparatus (Richmond, CA) according to Tow-
bin et al. [29]. The blotted ¢lter was blocked with
skim milk, probed with IgG a⁄nity-puri¢ed anti-
AQP5 antibody (13.6 Wg/ml in blocking solution),
and then incubated with 1:3000-diluted peroxidase-
Table 1
Primers for detection of AQP mRNAs by RT^PCR
mRNA Set number Primer Product size (bp)
AQP5 1 (sense, 5P-GCCACATCAATCCAGCCATT-3P) 383
(antisense, 5P-AAAGATCGGGCTGGGTTGAT-3P)
AQP5 2 (sense, 5P-CCCCAAGGCACCATGAAAAA-3P) 1073
(antisense, 5P-TCACGAATCTCTGAGGTCTG-3P)
AQP1 3 (sense, 5P-CTGTGGTGGCTGAGTTCCTG-3P) 344
(antisense, 5P-ATTTCGGCCAAGTGAGTTCTC-3P)
AQP2 4 (sense, 5P-ATGTGGGAACTCAGATCCATAGCCTTCTCC-3P) 816
(antisense, 5P-TCAGGCCTTGCTGCCGCGAGGCAGGCT-3P)
AQP3 5 (sense, 5P-GAGATGCTCCACATCCGCTAC-3P) 485
(antisense, 5P-CACACAATAAGGGCTGCTGTG-3P)
AQP4 6 (sense, 5P-CTCTGCTTTGGACTCAGCATTG-3P) 570
(antisense, 5P-TTCCTTTAGGCGACGTTTGAG-3P)
L-Actin 7 (sense, 5P-ACCCACACTGTGCCCATCTA-3P) 289
(antisense, 5P-CGGAACCGCTCATTGCC-3P)
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labeled anti-rabbit IgG. Anti-AQP5 antibody IgG
preabsorbed with AQP5 C-terminal peptide at a ¢nal
concentration of 40 Wg peptide/ml of antibody IgG
solution (13.6 Wg/ml) was also reacted with the blot-
ted ¢lter in place of non-preabsorbed antiserum to
verify the speci¢city of the band. All the ¢lters were
treated with chemical luminescence reagents (ECL
Detection kit) and exposed to X-ray ¢lms.
2.5. Immunohistochemistry
Fresh tissue specimens were ¢xed in 3% formalde-
hyde containing 0.1 M sodium phosphate bu¡er (pH
7.4) for 3 h on ice and equilibrated with PBS con-
taining 20% sucrose at 4‡C overnight. The specimens
were then embedded in Tissue-Tec Oct compound
and rapidly frozen in liquid nitrogen. Frozen sections
of 5-Wm thickness were cut, and ¢xed immediately in
ethanol at 320‡C [18]. The sections were washed in
PBS and blocked with 0.5% normal goat serum in
PBS and then incubated with IgG a⁄nity-puri¢ed
AQP5 antibody (13.6 Wg/ml in blocking solution;
primary antibody). After having been washed with
PBS, the sections were reacted with 200 times-diluted
£uorescein (FITC)-conjugated A⁄niPure goat anti-
rabbit IgG (H+L) (second antibody), and washed
with PBS. For control staining, some sections were
incubated with the same concentration of antibody
preabsorbed with the peptide as described above. All
sections were next incubated for 15 min at room
temperature with PBS containing 0.1 Wg/ml of propi-
dium iodide and 20 Wg/ml of RNase, and then
washed with PBS to allow the nucleus to become
stained.
The stained specimens were examined under a la-
ser confocal microscope (Leica TCN NT, Heidel-
berg, Germany) with excitation at 488 nm (for
FITC) and 568 nm (for propidium iodide).
3. Results
3.1. Detection of AQP5 mRNA in rat gastrointestinal
tract
RT^PCR analysis using an AQP5 primer set no. 1
(Table 1) indicated that rat lower stomach and duo-
denum expressed AQP5 mRNA as detected by the
appearance of its cDNA fragments (Fig. 1a, upper
panel); i.e., single bands of the expected size (383 bp)
of cDNA fragments were ampli¢ed when total RNA
from these tissues was used as a template. The cDNA
bands that appeared had the same size as those for
the submandibular gland, extraorbital lacrimal
gland, and lung, which were run as a positive control
(Fig. 1a, upper panel). The sequence determined for
the 383 bp products obtained from the lower stom-
ach and duodenum was identical to that reported for
rat submandibular gland AQP5 [6] (data not shown).
No RNA of any sample used in this experiment was
degraded as con¢rmed by the appearance of the L-
actin cDNA fragment (289 bp) upon ampli¢cation
with L-actin primers (Fig. 1a, lower panel). RT^
PCR ampli¢cation using a di¡erent AQP5 primer
set (Table 1, set no. 2) also gave the expected size
(1073 bp) of cDNA fragment (Fig. 1b). All these
data strongly suggest the expression of AQP5 in
the lower stomach and duodenum.
We next con¢rmed the expression of other AQPs
in the lower stomach and duodenum. mRNAs for
AQP1, AQP3, and AQP4 were found to be expressed
in these tissues (Fig. 2a,b), which expression pattern
Fig. 1. Detection of AQP5 mRNA in the gastrointestinal tissues
by RT^PCR. Aliquots of 0.5 Wg of total RNA were ampli¢ed
by RT^PCR, and the products were electrophoresed on 1.5%
agarose gel, and then stained with ethidium bromide (a,b). (a)
Upper panel: RT^PCR ampli¢cation using a set of AQP5
primers (Table 1, set no. 1). Lower panel : same RNA samples
as those used in the upper panel were ampli¢ed by using L-ac-
tin primers. (b) Ampli¢cation using a di¡erent set of AQP5
primers (Table 1, set no. 2). Lanes indicated as Sm, El, and L
are submandibular gland, extraorbital lacrimal gland, and lung,
respectively, run as positive controls. Lanes indicated as Us, Ls,
D, J, Il, C, Co, and R are upper stomach, lower stomach, duo-
denum, jejunum, ileum, caecum, colon, and rectum, respec-
tively.
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in the lower stomach and duodenum was similar to
that of other tissues in the gastrointestinal tract [22].
3.2. Detection of AQP5 protein in the lower stomach
and duodenum
Total membrane fractions or enriched apical mem-
brane fraction from the submandibular gland, lung,
lower stomach, and duodenum were analyzed by im-
munoblotting with an IgG the a⁄nity-puri¢ed anti-
AQP5 antibody. A 27 kDa AQP5 protein was de-
tected in the lower stomach and duodenum (Fig.
3a^d). When antibody was preabsorbed with AQP5
C-terminal peptide, the 27 kDa bands in the duode-
num completely disappeared (Fig. 3b), indicating the
speci¢city of the reaction with anti-AQP5 antibody.
The molecular mass of the band for the duodenum
sample was the same as the weights for submandib-
ular gland and lung, implying the expression of the
same molecular species of AQP5 in the duodenum.
Although a relatively intense signal for AQP5
mRNA was detected in the lower stomach, the pres-
ence of AQP5 protein in this tissue was not clear
from the Western blot when the total membrane
fraction was analyzed (Fig. 3a). However, its pres-
ence in the lower stomach became evident when the
enriched apical membrane fraction was analyzed
(Fig. 3c). The 27 kDa band clearly appeared in this
experiment, and this band disappeared completely
when the IgG a⁄nity-puri¢ed anti-AQP5 antibody
was preabsorbed with AQP5 peptide (Fig. 3d). These
data suggest a low level of expression of AQP5 pro-
tein in the lower stomach. This antibody also de-
tected an extra band (Mr 29 kDa) in the duodenum
as well as in the submandibular gland and lung but
not in the lower stomach (Fig. 3a,c). The presence of
a 29 kDa band in the submandibular gland has been
reported previously [30], but its nature is not clear at
present. There appeared a high molecular mass single
band around 66 kDa in the duodenum apical mem-
brane fraction (Fig. 3c), which was not found with
Fig. 2. Detection by RT^PCR of AQP1, AQP3, AQP4, and
AQP5 cDNA fragments produced from total RNA of the lower
stomach (a) and duodenum (b). Lanes 1^6 indicate the respec-
tive ampli¢cation of AQP1, AQP2, AQP3, AQP4, AQP5, and
L-actin cDNA fragment by using various sets of primers (Table
1, set nos. 1 and 3^7).
Fig. 3. Western blotting for detection of AQP5 in the lower stomach and duodenum of rats. Ten Wg protein of the total membrane
fraction (a,b) or apical membrane fractions (c,d) were subjected to SDS^PAGE, followed by Western blotting. Filters were probed
with IgG a⁄nity-puri¢ed anti-AQP5 antibody (a,c) or with the same antibody preabsorbed with AQP5 C-terminal peptide (b,d).
Lanes indicated as Sm, L, Ls, and D are the submandibular gland, lung, lower stomach, and duodenum, respectively. Arrowheads in-
dicate the position of AQP5 at 27 kDa.
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the peptide-preabsorbed AQP5 antibody (Fig. 3d).
The nature of this protein is not clear, although it
was speci¢cally recognized by the present antibody.
3.3. Immunohistochemical localization of AQP5 in the
lower stomach and duodenum
Immunohistochemical localization using the IgG
a⁄nity-puri¢ed anti-AQP5 antibody demonstrated
apparent staining in the lower stomach and duode-
num. We examined di¡erent parts of lower stomach
and found that all except pyloric area were negative
for AQP5 immunostaining. In the pyloric area of the
lower stomach, AQP5 immunostaining appeared in
the cells of the pyloric glands which were locating at
the bottom layer of the epithelium (Fig. 4a), and
were characterized by a large lumen and £attened
nucleus locating at the base of the cells (Fig. 4b).
A high-power magni¢cation photograph indicated
strong staining at apical membrane and moderate
staining at lateral membrane of these pyloric glands
but no staining at basal membrane (Fig. 4b). The
AQP5 antibody preabsorbed with peptide showed
no FITC £uorescence, indicating the present staining
was speci¢c.
Immuno£uorescence staining of the duodenum
showed a strong positive reaction in Brunner’s gland
(Fig. 5a), and there was no or very weak staining in
other parts of the duodenal tissue. Under high-power
magni¢cation, AQP5 localized at the apical and lat-
eral cell membranes of these glandular cells (Fig. 5b).
The basal membrane was stained only weakly for
AQP5. The positive staining seen at the apical/lateral
membrane completely disappeared when the sections
were stained with the same concentration of anti-
body solution preabsorbed with the peptide (Fig.
5c), clearly indicating that the positive staining seen
in Fig. 5a was due to a speci¢c reaction.
4. Discussion
In the present study AQP5 mRNA and protein
expression was detected in the lower stomach and
Fig. 4. Immunohistochemical localization of AQP5 in the lower stomach. Cryostat sections of lower stomach were stained with IgG
a⁄nity-puri¢ed anti-AQP5 antibody. The £uorescence image of FITC indicates the presence of AQP5 at the apical and lateral mem-
branes of the pyloric gland (a). Arrows in b indicate the apical and lateral cell membrane, and there was no staining at the basal
membrane. A control section incubated with antibody preabsorbed with AQP5 peptide shows no staining at cell membranes (c). E, ep-
ithelium; M, muscle.
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duodenum of the rat gastrointestinal tract. This con-
clusion was obtained on the basis of the data of RT^
PCR, cDNA sequencing, Western blotting, and im-
munohistochemistry (Figs. 1 and 3^5). By immuno-
histochemistry, AQP5 was found to be localized in
the pyloric gland of the lower stomach and also in
Brunner’s gland of the duodenum. To our knowl-
edge, this is the ¢rst immunohistochemical and mo-
lecular biological study demonstrating the expression
and cellular localization of AQP5 in the gastrointes-
tinal tract. This ¢nding is in good accordance with
one of the common features of AQP5, i.e., its expres-
sion primarily in exocrine glands in general, many of
which exist in the gastrointestinal tract.
Earlier, Raina et al., the discoverers of AQP5, re-
ported that no signal for AQP5 could be detected in
the intestine, kidney, or brain by Northern blotting
[6]. Koyama et al., using in situ hybridization, also
failed to detect AQP5 expression in the gastrointes-
tinal tract [22]. The apparent discrepancy between
their results and our data may be explained by the
di¡erential sensitivity of the procedures employed;
i.e., RT^PCR is a more sensitive technique than
Northern blotting and in situ hybridization. The
low-level expression we detected by the above proce-
dures is supported by the fact that the expression
level of AQP5 protein in the lower stomach and du-
odenum was low when compared with the relative
amounts seen in the submandibular gland or lung
(Fig. 3).
In cells of salivary and lacrimal glands, and in
type-1 pneumocytes in the distal lung, AQP5 is lo-
calized at the apical membrane [31,14]; whereas ei-
ther AQP3 or AQP4 or both of them are localized at
the basal membrane [22,32]. In the tissues of the
digestive tract, the expression of AQP5 had not
been established although the presence of AQP3
and/or AQP4 was evident [22,32], as was con¢rmed
in the present study (Fig. 2). In previous studies
cited, AQP3 and AQP4 were detected in the cells
of cardiac glands and in parietal cells, both at the
basolateral membranes [22]. In the present study, the
immunohistochemical examination of the lower
stomach and duodenum localized AQP5 at the apical
Fig. 5. Immunohistochemical localization of AQP5 in the duodenum. The cryostat sections was prepared and stained in the same way
as for Fig. 4. The £uorescence image of FITC indicates the presence of AQP5 at the apical and lateral membranes of Brunner’s gland
(a), the location of which is more prominent at higher magni¢cation (b), and there was a weak staining at the basal membrane (b).
Arrows in b indicate the apical and lateral cell membrane. A control section incubated with antibody preabsorbed with AQP5 peptide
shows no staining at cell membranes (c). V, villi ; B, Brunner’s gland; M, muscle.
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and lateral membrane of the pyloric gland and Brun-
ner’s gland (Figs. 4 and 5). AQP5 is known to be
expressed in the variety of exocrine gland cells in
addition to type-1 pneumocytes cells, e.g., in parotid
and lacrimal gland acinar cells (serous cells) and in
submandibular and sublingual gland acinar cells
(mucous cells) [31]. Therefore, both serous and mu-
cous glands appear to express AQP5, although the
di¡erence in its physiological function in the two
types of glands is not fully understood. The pyloric
gland and Brunner’s gland are composed of mucous
cells, and thus the present ¢nding is in accordance
with the known distribution of AQP5 in the exocrine
gland of the rat.
In many organs, water is absorbed when the sym-
porter transports K/Cl3, Na/glucose, and other
substrates [33]. In vitro system, Na/glucose trans-
porter has been shown to transport 390 water mole-
cules per glucose molecule [33,34]. In the gastrointes-
tinal tract, therefore, the major part of water is
supposed to be absorbed by Na/glucose transporter.
On the contrast, water secretion in this tract is
a¡ected by gastrointestinal hormones (gastrin, VIP,
and others), neurotransmitters, histamine, and other
hormones (such as epidermal growth factor) [35]. It
may be possible that one or some of these hormones
a¡ect the function of AQPs including AQP5 and
thereby regulate water transport. In fact, in the
watery diarrhea syndrome of Verner and Morrison
(WDHA syndrome), VIP produced and released by a
tumor of the pancreatic islets or by a tumor of neural
crest origin such as a ganglioneuroma causes strong
water secretion from intestine [36].
Tra⁄cking of AQP5 is thought to be involved in
the regulation of water transport via this channel
protein like that of AQP2. In the salivary glands
culture cells transfected with AQP5 cDNA, vesicles
containing AQP5 have recently been shown to move
toward the apical membrane upon an increase in
[Ca2]i [23]. Both AQP2 and AQP5 are known to
have a protein kinase A (PKA) target motif,
although its function in relation to water transport
is not completely understood. Moore et al. reported
that VIP and other gastrointestinal hormones a¡ects
the duodenal Brunner’s gland and enlarge the lumen
of this gland [35]. This ¢nding suggests that Brun-
ner’s gland expresses receptors for VIP and other
intestinal hormones. It may be possible therefore
that the function of AQP5 is regulated by VIP and/
or other intestinal hormones in Brunner’s gland. This
possibility is now being investigated both in vitro
and in vivo experiments.
Since AQP5 was found to be strongly expressed in
the mucous pyloric gland and duodenal Brunner’s
gland, these glands may be involved in water secre-
tion in the gastrointestinal tract. However, the level
of AQP5 contribution in this process was not deter-
mined in the present study. AQP5 may not be the
only AQP that largely contributes to the water trans-
port in other tissues of the gastrointestinal tract. A
combination of plural species of AQPs or yet un-
known AQPs may be important for such water trans-
port, since the expression of AQP5 in these tissues
was low compared with that in other exocrine glands
such as the submandibular gland.
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